Introduction: The use of preoperative and postoperative mammograms in cosmetic surgery has never been standardized. This article discusses the medical benefits and legal issues of preoperative and postoperative mammograms in cosmetic breast surgery.
Method: Review of the literature and a retrospective review of case.
Results: The purpose of a preoperative mammogram is to detect any significant disorder of the breast(s) before cosmetic surgery so that the problem can be resolved before or during surgery. After cosmetic breast surgery, routine mammograms (6 to 12 months after surgery) help to formulate a baseline for the future detection of breast cancer. The changes that result from cosmetic breast surgeries, such as architectural scars, calcifications that form around an implant or around fat necrosis, and tissue thickenings make it more difficult to distinguish surgery artifacts from cancerous tumors.
Discussion: It is the surgeon's choice whether to order a mammogram before cosmetic breast surgery on a patient under the age of40. Patients under the age of40 who refuse to have a requested preoperative mammogram may be safely operatedupon, but the refusal should be noted in the medical record. This will help to protect the physician if there is future litigation. It is also the physician's choice whether to do cosmetic breast surgery on patients over the age of 40 who refuse a preoperative mammogram.
Conclusion: Whether a mammogram is performed or not, the patient should be fully informed of the possible consequences of missing a significant abnormality early before surgery and that an implant or cosmetic surgery may reduce the chance of early detection of cancer.
T he use of preoperative and postoperative mammograms in cosmetic surgery has never been Received for publication July 17, 2007 standardized. 1 There appears to be some consensus that at least preoperative mammograms should be obtained according to the recommendations of the American Cancer Society for screening mammography. Women at average risk should begin monthly self-breast examination at age 20, clinical breast examination every 3 years from age 20 to 39, and annual mammogram and clinical breast examination starting at age 40. 1 There is no specific surveillance strategy for women at higher risk for breast cancer, but these patients may benefit from earlier initiation of screening, screening at shorter intervals, and screening with additional methods, such as ultrasound or magnetic resonance imaging.i
Preoperative Mammogram
The purpose of a preoperative mammogram is to detect any clinically significant disorder of the breast(s) before cosmetic surgery so that the problem can be resolved before or during surgery. Also, the mammogram is a baseline for detecting abnormalities after the cosmetic surgery.
The incidence of new breast cancer cases is increasing at a yearly rate and was estimated to be 203 500 in 2002 3 and 211 300 in 2003 in the United States." Thus, it is essential to detect cancer early so that cosmetic procedures of the breast do not cut across, distort, or diminish the opportunity for cure, or limit the usefulness of lumpectomy in the treatment of the cancer. Through the use of mammograms, breast cancer is now being detected earlier in the development of the tumor, at a smaller size, and with a better prognosis for cure.
Detection of a fibroadenoma is clinically significant because carcinoma may occur within the fibroadenoma. 5 -11 The average age for fibroadenoma is 23, whereas the average age for carcinoma in the fibroadenoma is 43. 5 A new tumor after age 35 should be biopsied (most commonly with stereotactic needle biopsy). Under age 35 a fibroadenoma would need to be biopsied or excised if it continues to grow.
Debate continues over whether or not to perform preoperative mammograms in 18-to 40-year-old patients. This age group has not had a high incidence of breast cancer but there is presently a higher incidence than previously reported because of earlier diagnosis. The average breast cancer tumor size in the author's practice was 3.0 em from 1964 to 1985 and from 1985 to 2000 it was 2.0 em, which suggests that earlier diagnosis is being made through mammographic screening methods and better patient awareness of the need for regular examinations. Breast cancer has been reported in patients under the age of 30. 12 The youngest patient with cancer seen by the author was 16 years old. Radiologists have argued that youthful breasts have marked dysplasia on mammogram, which prevents the detection of some abnormalities. By increasing the radiation slightly to eliminate some of the dysplastic changes, however, a mammogram can be performed that will then focus on architectural distortion and calcifications.
Patients with a significant family history of breast cancer should begin to have annual mammograms 10 years before the youngest age of the persons in the family who had cancer. If a patient with a significant family history desires breast augmentation, then the patient must be forewarned of the problems associated with the implant: for example, the implant may reduce the chance of early detection of cancer and consideration should be given to placing the implant beneath the pectoralis major muscle.
Postoperative Mammograms After
Cosmetic Breast Surgery After cosmetic breast surgery, routine postoperative mammograms (at 6 to 12 months) help to formulate a baseline for the future detection of breast cancer. Surgery involving the breasts can result in architectural distortion from scars and calcifications.
Cosmetic Surgeries
Breast Augmentation Inserting implants through areola or periareo1a incisions usually involves dissection through the breast tissues, which may result in architectural scars within the breast tissue. Axillary, inframammary, and umbilical approaches do not usually breach the breast tissue itself. Calcifications have been reported in the fibrous capsule (around the implant) but do not resemble the calcifications seen with breast cancer. [13] [14] [15] [16] [17] [18] For implants in place for more than 12 years, 52.5% of those that The American Journal of Cosmetic Surgery Vol. 25, No. 2, 2008 ruptured showed calcification, but only 10.0% of intact implants showed calcification. 14 Fat transfer into the breast parenchyma is no longer performed.'? Fat for augmentation is now injected beneath, into, and above the pectoralis muscle, although the patient should be forewarned of the possibility of inadvertent injection into the breast itself. Calcifications around a fat cyst are easily diagnosed as benign.i" Stippled calcifications of fat necrosis after fat injection appear circular and smooth and can usually be distinguished by an experienced mammographer from calcifications found with cancer. If there is any question, the calcified area can be sampled through stereotactic needle biopsy under local anesthesia.
Kinoshita et al 2 1 stated that in some magnetic resonance (MR) findings of fat necrosis it was difficult to distinguish benign from malignant lesions. Kurtz et at2 2 studied MR findings in patients with fat necrosis and found that all 15 fat necroses displayed fatisointense signal on T'l-weighted or proton-weighted, fat-suppressed sequences. They were delineated by a more or less wide rim of low signal intensity with a sharp border to the center. After intravenous injection of gadopenetate dimeglumine, they showed no increase in signal intensity in the center and no increase, or a minor increase, of the rim. Ultrasound could not distinguish fat necrosis from recurrent tumor in 6 cases although 7 looked like atypical cysts. MR mammography was thought to be a promising method for diagnosis of fat necrosis.
Bilgen et al 23 studied 126 fat necrosis lesions in 94 patients. On mammogram they found radiolucent oil cyst (34 or 26.9%), round opacity (16 or 12.6%), asymmetrical opacity or heterogenicity of the subcutaneous tissues (20 or 15.8%), dystrophic calcifications (5 or 3.9%), and suspicious spiculated mass (5 or 3.9%). Follow-up mammograms showed curvilinear calcifications in 5 and decreased density in 6 rounded opacities with another 2 disappearing. In addition, 11 dystrophic calcifications became more coarse, 6 of the asymmetrical opacities became vague, 1 of the asymmetrical developed an oil cyst and coarse calcifications, and 1 spiculated mass developed a small radiolucent oil cyst in the center. On sonogram the lesions were solid in 18 (9.5%), anechoic with posterior acoustic enhancement in 21 (16.6%), anechoic with posterior acoustic shadowing in 20 (15.8%), cystic with internal echoes in 14 (11.1%), cystic with mural nodule in 5 (3.9%), and normal in 14 (11.1%). In addition, increased echogenicity of the subcutaneous tissues was found in 34 (26.9%). Follow-up ultrasound showed that 18 of the 29 had increased subcutaneous tissue echogenicity that turned back to normal, and small cysts formed in the remaining 11. In the 19 solid appearing masses, 15 decreased in size and 4 remained stable (biopsy disclosed fat necrosis). The 4 complex masses increased in size and appeared more cystic. It was concluded that knowledge of the mammographic and ultrasound appearance of fat necrosis and evolution of these patterns may enable imaging follow-up and reduce the number of biopsies.
Breast Reduction
Breast reduction involves cutting into and removal of areas of breast tissue, which may result in significant scarring, architectural distortion, and calcifications, usually from fat necrosis." Miller et al 2s noted that afterreduction mammoplasty, all patients were left with a linear scar between the nipple and inframammary fold that accounts for the frequent finding of skin thickening along the lower breast. Fat necrosis presents as an irregular calcified mass. Brown et ae 6 noted that asymmetric densities were present in approximately half the patients. Parenchymal calcifications were apparent in 50% of patients after 2 years. Of 42 patients studied, 4 had biopsies for suspicious densities, which were benign on pathology.
Abboud et ae 7 reported that breast reduction using liposuction has been associated with calcifications from fat necrosis. Sixty patients with breast reduction were studied: 34 with liposuction and 26 without. There was a 6-to 30-month follow-up, and calcifications were noted in 11%. Deep intraparenchymal calcifications were more frequent after liposuction and most (5 of 7) were macrocalcifications. None could be confused with malignant calcifications because they were more scattered, more regular, and less numerous. If there is any question as to the cause of the calcifications, stereotactic needle biopsy should be performed. Alterations in breast tissue resulting from the use of ultrasound-assisted liposuction were a thickened dermal undersurface, markedly thickened vertical collagenous fibers with intact lymphatic vessels, and intact blood vessels.i" The use of ultrasound-assisted liposuction for breast reduction has not been found to be injurious to the breast tissue but still may be associated with calcifications. 29 ,30 Mastopexy Breast lift (mastopexy) does not usually disturb the breast parenchyma unless there is some breast tissue reduction. The lift is mainly a skin reduction with 107 release of the breast from the underlying muscle to reorient the breast into a higher position.
Discussion
Preoperative mammograms are a screening technique to detect abnormalities before performing cosmetic surgery. Some argue that because cosmetic surgery is an elective procedure being performed on a healthy patient, there should be a more detailed workup with mammography to protect patients, even those in the young age group, before breast surgery. This would mean that every patient, no matter what age, should have a mammogram before cosmetic breast surgery (R. Jackson, unpublished data, April 24, 2003) . Peras" reported that in 1149 cases of cosmetic surgery, early diagnosis of breast cancer was possible in 34 cases by use of mammography. He strongly recommended that a policy of mandatory preoperative mammography be implemented so that all patients can be protected from a potentially lethal disease by early detection.
It is the surgeon's choice whether to order a mammogram before cosmetic breast surgery on patients younger than 40 years. Patients under the age of 40 who refuse to have a requested preoperative mammogram may be safely operated upon, but the refusal should be noted in the medical record. This will help to protect the physician if there is future litigation. It is also the physician's choice whether to do cosmetic breast surgery on a patient older than 40 years who refuses a preoperative mammogram. The patient should be fully informed of the possible consequences of missing a significant abnormality.
Postoperative mammograms will protect the patient by obtaining a baseline for future reference. However, many patients do not return to the surgeon for follow-up mammography because they feel fine and do not wish to be bothered with the procedure or the cost. The surgeon should probably document in the medical record that a postoperative mammogram was requested.
The patient who has a significant family history of breast cancer should be counseled on the possibility of future breast cancer and the possible need for genetic testing before any cosmetic procedure on the breast. If genetic testing is positive for BRCA 1 or BRCA2, there is a 50% to 90% lifetime risk of developing breast cancer. [32] [33] [34] [35] If the genetic abnormality is present, a variety of early detection and prevention programs are available. 36 Patients of any age who have a clinically significant family history should have a mammogram before any cosmetic breast surgery is contemplated.
The problems of early diagnosis of breast cancer that may be present if augmentation mammoplasty or any other cosmetic procedure of the breast is performed should be thoroughly explained before making any decisions about surgery.
